阿尔茨海默病药物治疗的研究进展

被引：20

作者：

谢荣源

机构：

[1] 美国哥伦比亚大学化学系

来源：

常州大学学报(自然科学版) | 2014年 / 26卷 / 03期

关键词：

阿尔茨海默病; 药物治疗; β-淀粉样蛋白;

D O I：

暂无

中图分类号：

R749.16 [];

学科分类号：

摘要：

综述了阿尔茨海默病的药物治疗研究进展,包括乙酰胆碱酯酶抑制剂,NMDA受体拮抗剂,非甾体类抗炎药,抗氧化剂,免疫治疗以及针对Aβ的其它治疗手段等。

引用

页码：56 / 63

页数：8

共 16 条

[1]

阿尔茨海默病的发病机制及营养调节 [J].

王鸿飞 ;

安丽 .

国际老年医学杂志, 2010, 31 (05) :230-234

[2]

Disease-modifying drugsin Alzheimer''s disease..Laura Ghezzi;Elio Scarpini;Daniela Galimberti;.Drug Design; Development and Therapy.2013,

[3]

Acetylcholinesterase inhibitors: a patent review (2008 – present).[J].Miroslav Pohanka.Expert Opinion on Therapeutic Patents.2012, 8

[4]

Multi-Target-Directed Ligands in Alzheimer's Disease Treatment [J].

Bajda, M. ;

Guzior, N. ;

Ignasik, M. ;

Malawska, B. .

CURRENT MEDICINAL CHEMISTRY, 2011, 18 (32) :4949-4975

[5]

Immunotherapy for Alzheimer’s disease.[J].D.Morgan.Journal of Internal Medicine.2010, 1

[6]

Alzheimer's disease as homeostatic responses to age-related myelin breakdown.[J].George Bartzokis.Neurobiology of Aging.2009, 8

[7]

A novel pathway for amyloid precursor protein processing.[J].Erik Portelius;Eric Price;Gunnar Brinkmalm;Mark Stiteler;Maria Olsson;Rita Persson;Ann Westman-Brinkmalm;Henrik Zetterberg;Adam J. Simon;Kaj Blennow.Neurobiology of Aging.2009, 6

[8]

Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing [J].

Ryan, J. Michael ;

Grundman, Michael .

JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (02) :243-243

[9]

Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial [J].

Holmes, Clive ;

Boche, Delphine ;

Wilkinson, David ;

Yadegarfar, Ghasem ;

Hopkins, Vivienne ;

Bayer, Anthony ;

Jones, Roy W. ;

Bullock, Roger ;

Love, Seth ;

Neal, James W. ;

Zotova, Elina ;

Nicoll, James A. R. .

LANCET, 2008, 372 (9634) :216-223

[10]

Forecasting the global burden of Alzheimer's disease [J].

Brookmeyer, Ron ;

Johnson, Elizabeth ;

Ziegler-Graham, Kathryn ;

Arrighi, H. Michael .

ALZHEIMERS & DEMENTIA, 2007, 3 (03) :186-191

← 1 2 →